Suppression of glutamate-induced excitotoxicity by 2-cyclopropylimino-3- methyl-1,3-thiazoline hydrochloride in rat glial cultures

Cellular and Molecular Neurobiology

Volumn 30, Issue 5, 2010, Pages 807-815

  Kim, Eun A ^a,b   Hahn, Hoh Gyu ^c   Kim, Key Sun ^c   Kim, Tae Ue ^b   Choi, Soo Young ^d   Cho, Sung Woo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Hallym University   (South Korea)

Author keywords

Catenin; 2 cyclopropylimino 3 methyl 1,3 thiazoline hydrochloride; Calcium; Cytokines; Glutamate; GSK 3 ; Nitric oxide

Indexed keywords

2 CYCLOPROPYLIMINO 3 METHYL 1,3 THIAZOLINE; BETA CATENIN; CALCIUM ION; CYTOCHROME C; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; NEUROPROTECTIVE AGENT; NEW DRUG; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CANCER CELL CULTURE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SYNTHESIS; ENZYME RELEASE; EXCITOTOXICITY; GLIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

ANIMALS; BETA CATENIN; CALCIUM; CELLS, CULTURED; CYTOCHROMES C; CYTOKINES; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3; INFLAMMATION MEDIATORS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEUROGLIA; NITRITES; PROTECTIVE AGENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; THIAZOLES;

RATTUS;

EID: 77956264216     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-010-9508-x     Document Type: Article

References (48)

1. Adrain C, Creagh EM, Martin SJ (2001) Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 20:6627-6636
2. Allan SM, Tyrrell PJ, Rothwell NJ (2005) Interleukin-1β and neuronal injury. Nat Rev Immunol 5:629-640
3. Aloisi F (2001) Immune function of microglia. Glia 36:165-179
4. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366
5. Bhat NR, Zhang P, Lee JC, Hogan EL (1998) Extracellular signalregulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633-1641
6. Cadigan KM, Liu YI (2006) Wnt signaling: complexity at the surface. J Cell Sci 119:395-402
7. Chaparro-Huerta V, Rivera-Cervantes MC, Flores-Soto ME, Gomez-Pinedo U, Beas-Zarate C (2005) Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. J Neuroimmunol 165:53-62
8. Cheng HY, Hsieh MT, Wu CR, Tsai FH, Lu TC, Hsieh CC, Li WC, Lin YT, Peng WH (2008) Schizandrin protects primary cultures of rat cortical cells from glutamate-induced excitotoxicity. J Pharmacol Sci 107:21-31
9. Cheng Y-L, Wang C-Y, Huang W-C, Tsai C-C, Chen C-L, Shen C-F, Chi C-Y, Lin C-F (2009) Staphylococcus aureus induces microglial inflammation via a glycogen synthase kinase 3β-regulated pathway. Infect Immunol 77:4002-4008
10. Choi M-M, Kim E-A, Hahn HG, Nam KD, Yang S-J, Choi SY, Kim TU, Cho S-W, Huh J-W (2007) Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 239:156-166
11. Chong ZZ, Li F, Maiese K (2007) Cellular demise and inflammatory microglial activation during β-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell Signal 19:1150-1162
12. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13:2651-2661
13. Duchen M (2000) Mitochondria and calcium: from cell signaling to cell death. J Physiol 529:57-68
14. Dugo L, Collin M, Thiemermann C (2007) Glycogen synthase kinase 3β as a target for the therapy of shock and inflammation. Shock 27:113-123
15. Fumagalli E, Funicello M, Rauen T, Gobbi M, Mennini T (2008) Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol 578:171-176
16. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450
17. 2+ overload and glutamate release. Eur J Pharmacol 603:50-55
18. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR (2000) Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406:86-90
19. Huang L, Tang D, Yappert MC, Borchman D (2006) Oxidationinduced changes in human lens epithelial cells 2. Mitochondria and the generation of reactive oxygen species. Free Radic Biol Med 41:926-936
20. Huang WC, Lin YS, Wang CY, Tsai CC, Tseng HC, Chen CL, Lu PJ, Chen PS, Qian L, Hong JS, Lin CF (2009) Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 128: e275-e286
21. Javitt DC (2004) Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 9:984-997
22. Kim SR, Sung SH, Kwon SW, Park JH, Huh H, Kim YC (2000) Dammarane derivatives protect cultured rat cortical cells from glutamate-induced neurotoxicity. J Pharm Pharmacol 52:1505-1511
23. Kim SD, Yang S-I, Kim H-C, Shin CY, Ko KH (2007) Inhibition of GSK-3β mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-κB in rat primary astrocyte. Brain Res 1186:12-20
24. Korhonen R, Lahti A, Kankaanranta H, Molanen E (2005) Nitric oxide production and signalling in inflammation. Curr Drug Targets Inflamm Allergy 4:471-479
25. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318
26. Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH (2009) Structure-activity relationships comparing N-(6-methylpyridin-yl)- substituted aryl amides to 2-methyl-6-(substituted-arylethynyl) pyridines or 2-methyl-4-(substituted-arylethynyl) thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists. J Med Chem 52:3563-3575
27. Lee JH, Lee EO, Kang JL, Chong YH (2008) Concomitant degradation of β-catenin and GSK-3β potently contributes to glutamate-induced neurotoxicity in rat hippocampal slice cultures. J Neurochem 106:1066-1077
28. Liu F, Gong X, Zhang G, Marquis K, Reinhart P, Andree TH (2005) The inhibition of glycogen synthase kinase 3β by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Aβ peptides. J Neurochem 95:1363-1372
29. Luetjens CM, Bui NT, Sengpiel B, Munstermann G, Poppe M, Krohn AJ, Bauerbach E, Krieglstein J, Prehn JH (2000) Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production. J Neurosci 20:5715-5723
30. Maiese K, Vincent AM (1999) Group I metabotropic receptors downregulate nitric oxide induced caspase-3 activity in rat hippocampal neurons. Neurosci Lett 264:17-20
31. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T (2002) Inflammatory response in acute traumatic brain injury: a doubleedged sword. Curr Opin Crit Care 8:101-105
32. Mukhin A, Fan L, Faden AL (1996) Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury. J Neurosci 16:6012-6020
33. Munoz-Fernandez MA, Fresno M (1998) The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56:307-340
34. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487
35. Olney JW (2003) Excitotoxicity, apoptosis and neuropsychiatric disorders. Curr Opin Pharmacol 3:101-109
36. Satoh A, Nagatomi Y, Hirata Y, Ito S, Suzuki G, Kimura T, Maehara S, Hikichi H, Satow A, Hata M, Ohta H, Kawamoto H (2009) Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino) pyrimidin-4-yl]-1, 3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist. Bioorg Med Chem Lett 19:5464-5468
37. Schousboe A, Sonnewald U, Civenne G, Gegelashvili G (1997) Role of astrocytes in glutamate homeostasis. Implications for excitotoxicity. Adv Exp Med Biol 429:195-206
38. Smith T, Groom A, Zhu B, Turski L (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6:62-66
39. Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB (2004) Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J Biol Chem 279:39541-39554
40. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580-2588
41. Venters HD, Dantzer R, Kelley KW (2000) A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci 23:175-180
42. Wang CX, Schuaib A (2002) Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 67:161-172
43. Wang JQ, Fibuch EE, Mao L (2007) Regulation of mitogen-activated protein kinases by glutamate receptors. J Neurochem 100:1-11
44. 2+ dependent NO-production form central nervous system cells in culture measured by NO-nitrite/ozone chemoluminescence. Brain Res 748:1-11
45. Woodgett JR, Ohashi PS (2005) GSK3: an in-Toll-erant protein kinase? Nat Immunol 6:751-752
46. Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease-a double-edged sword. Neuron 35:419-432
47. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496-13500
48. Yuskaitis CJ, Jope RS (2009) Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal 21:264-273